Working… Menu

Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02953860
Recruitment Status : Active, not recruiting
First Posted : November 3, 2016
Last Update Posted : December 11, 2019
United States Department of Defense
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 2, 2019
Estimated Study Completion Date : November 2021